H
Heather Cubie
Researcher at University of Edinburgh
Publications - 89
Citations - 4523
Heather Cubie is an academic researcher from University of Edinburgh. The author has contributed to research in topics: Cervical screening & Cervical cancer. The author has an hindex of 33, co-authored 89 publications receiving 4182 citations.
Papers
More filters
Journal ArticleDOI
Management of women who test positive for high-risk types of human papillomavirus: The HART study
Jack Cuzick,Anne Szarewski,Heather Cubie,G Hulman,Henry C Kitchener,David Luesley,Euphemia McGoogan,Usha Menon,George Terry,Robert Edwards,Claire Brooks,Mina Desai,C Gie,Linda Lee Ho,Ian Jacobs,C Pickles,Peter Sasieni +16 more
TL;DR: Comparison of the detection rate and positive predictive values of HPV assay with cytology and the best management strategy for HPV-positive women found HPV testing was more sensitive than borderline or worse cytology but less specific for detecting CIN2+.
Journal ArticleDOI
Comprehensive control of human papillomavirus infections and related diseases.
F. Xavier Bosch,Thomas R. Broker,David Forman,Anna-Barbara Moscicki,Maura L. Gillison,John Doorbar,Peter L. Stern,Margaret Stanley,Marc Arbyn,Mario Poljak,Jack Cuzick,Philip E. Castle,John T. Schiller,Lauri E. Markowitz,William A. Fisher,Karen Canfell,Lynette Denny,Eduardo L. Franco,Marc Steben,Mark A. Kane,Mark Schiffman,Chris J.L.M. Meijer,Rengaswamy Sankaranarayanan,Xavier Castellsagué,Jane J. Kim,Maria Brotons,Laia Alemany,Ginesa Albero,Mireia Diaz,Silvia de Sanjosé,Ahti Anttila,Lawrence Banks,Christine Bergeron,Jerome L. Belinson,Johannes Berkhof,Ignacio G. Bravo,Freddie Bray,Julia M.L. Brotherton,Laia Bruni,Ann N. Burchell,Anil K. Chaturvedi,Harrell W. Chesson,Myriam Chevarie-Davis,Heather Cubie,Shelley L. Deeks,Catherine de Martel,Joakim Dillner,Mark H. Einstein,Jacques Ferlay,Alison Nina Fiander,Silvia Franceschi,Suzanne M. Garland,Anna R. Giuliano,Marc T. Goodman,Patti E. Gravitt,Ian N. Hampson,Isabelle Heard,Thomas Iftner,Sandra D. Isidean,Christina Jensen,Jose Jeronimo,Walter Kinney,Henry C Kitchener,Susanne K. Kjaer,Boŝtjan J. Kocjan,George Koliopoulos,Shalini L Kulasingam,Charles J.N. Lacey,D. Scott LaMontagne,Eduardo Lazcano-Ponce,Attila T. Lorincz,Joannie Lortet-Tieulent,Pontus Naucler,Gina Ogilvie,Joel M. Palefsky,Julian Peto,Ligia A. Pinto,Martyn Plummer,You-Lin Qiao,Wim Quint,Guglielmo Ronco,Steve Schwartz,Beatriz Serrano,Jennifer S. Smith,Peter J.F. Snijders,Isabelle Soerjomataram,Bettie M. Steinberg,Mark H. Stoler,Anne Szarewski,Connie Trimble,Vivien Tsu,Pierre Van Damme,Sjoerd H. van der Burg,Andrea Vicari,Jérôme Vignat,Magnus von Knebel Doeberitz,Alex Vorsters,Susan A. Wang,Scott Wittet +98 more
TL;DR: There must be ongoing efforts including international advocacy to achieve widespread-optimally universal-implementation of HPV prevention strategies in both developed and developing countries.
Journal ArticleDOI
Human Papillomavirus Vaccine Introduction – The First Five Years
Lauri E. Markowitz,Vivien Tsu,Shelley L. Deeks,Heather Cubie,Susan A. Wang,Andrea Vicari,Julia M.L. Brotherton +6 more
TL;DR: In the 5 years since HPV vaccines were licensed, there have been successes as well as challenges with vaccine introduction and implementation, and further progress is anticipated in the coming years, especially in low- and middle-income countries where the need for vaccine is greatest.
Journal ArticleDOI
Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population.
Kate Cuschieri,Heather Cubie,M W Whitley,A L Seagar,Mark J. Arends,Catherine Moore,G Gilkisson,Euphemia McGoogan +7 more
TL;DR: Prospective cohort studies linking sequential loss or gain of HPV types with cytological analysis are required to assess the impact of multiple HR-HPV infections on neoplastic progression.
Journal ArticleDOI
Diseases associated with human papillomavirus infection.
TL;DR: This chapter sets out the range of infections and clinical manifestations of the consequences of infection and its persistence and describes why HPVs are both highly effective pathogens and carcinogens, challenging to eliminate.